Photo Release -- NASDAQ Welcomes HealthEquity, Inc.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Photo Release -- NASDAQ Welcomes HealthEquity, Inc. (NASDAQ: HQY) to The NASDAQ Stock Market

NEW YORK, July 31, 2014 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq: NDAQ ) announced that trading of HealthEquity, Inc. (Nasdaq: HQY ), one of the nation's largest dedicated health savings custodians, commenced on The NASDAQ Stock Market on July 31, 2014.

A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=26814 .

Founded in 2002, HealthEquity is a leader and an innovator in the high growth category of technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company's innovative technology platform and tax-advantaged accounts help members build health savings, while controlling health care costs. HealthEquity works with 57 health plan partners and services more than 1.3 million healthcare accounts for employees at 25,000+ companies across the United States.

"HealthEquity is dedicated to empowering Americans to build health savings through its tools and services," said Nelson Griggs, Senior Vice President, Corporate Client Group, NASDAQ OMX. "We congratulate HealthEquity on its successful initial public offering and we are pleased to welcome the company to the NASDAQ family."

By listing with NASDAQ, HealthEquity joins some of the world's largest and most revolutionary healthcare companies. NASDAQ has been the exchange of choice to 93 percent of healthcare companies that have listed on the U.S. markets year-to-date in 2014.

The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding NASDAQ-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

About The NASDAQ OMX Group

NASDAQ OMX (Nasdaq: NDAQ ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, NASDAQ OMX enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. NASDAQ OMX is home to more than 3,400 listed companies with a market value of over $8.5 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaqomx.com .

The photo is also available via AP PhotoExpress.

NDAQG

MEDIA RELATIONS CONTACT: Will Briganti (646) 441-5012 Christine Barna (646) 441-5310

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Next Ventures Invests in BranchLab to Enhance Healthcare AI

Updated Category News Views 201

Next Ventures Makes Strategic Investment in BranchLab Next Ventures, a prominent venture capital firm dedicated to fostering advancements in whole-person health, has made an exciting strategic investment in BranchLab, a leader in AI-driven solutions for healthcare marketing. This collaboration aims to shift healthcare towards a proactive and interconnected model that...

Continue Reading
Cytokinetics Highlights Promising Aficamten Data for HCM

Updated Category News Views 204

Cytokinetics, Incorporated (Nasdaq: CYTK) made waves back in 2024 when they released data from their pivotal Phase 3 clinical trial SEQUOIA-HCM, focusing on the investigational drug aficamten. This treatment targets symptomatic obstructive hypertrophic cardiomyopathy (HCM), a condition that can wreck lives with its debilitating symptoms. The big reveal came at the Heart...

Continue Reading
Totalkredit A/S: Comprehensive Insights into Cash Flows

Updated Category News Views 169

Overview of Cash Flows at Totalkredit A/S At Totalkredit A/S, we emphasize transparency and clarity in our financial disclosures. Recently, we have conducted a comprehensive analysis of cash flows, focusing on various loan types including open and closed annuities, index-linked loans, and serial loans. This analysis reflects our commitment to maintaining robust financial...

Continue Reading
Bitcoin Approaches $70,000 Amid Regulatory Optimism

Updated Category News Views 47

Bitcoin's steady climb towards the $70,000 mark back in 2024 was no accident—traders were watching the charts closely as a wave of inflows into exchange-traded funds (ETFs) linked to this digital heavyweight kicked off a bullish sentiment. With Bitcoin hovering around $68,720 during that time, it was clear that the market was feeling jittery, especially given how...

Continue Reading
Corporate Visions Welcomes Dom Maida to Enhance AI Strategy

Updated Category News Views 146

Corporate Visions Welcomes Industry Leader to Board Corporate Visions, a recognized leader in evidence-based revenue growth solutions, has announced the appointment of tech veteran Dom Maida to its Board of Directors. Maida is known for his extensive experience in data, technology, and product development, especially from his tenure at Bloomberg where he served as Chief...

Continue Reading